title: Perillyl alcohol selectively induces G0/G1 arrest and apoptosis in Bcr/Abl-transformed myeloid cell lines.
abstract: The Bcr/Abl tyrosine kinase that is expressed from the Philadelphia chromosome protects leukemia cells from apoptosis caused by removal of growth factors or by cytotoxic agents and ionizing irradiation. This resistance to apoptosis is associated with a Bcr/Abl-mediated G2/M delay. Therefore, inhibiting Bcr/Abl signaling pathways should block the ability of the Bcr/Abl kinase to protect cells from apoptosis. The monoterpenes, limonene and perillyl alcohol (POH) are new anticancer agents that selectively induce apoptosis in neoplastic cells of a variety of rodent carcinoma models. Since the potential antitumor activities of monoterpenes overlap with signaling pathways affected by the Bcr/Abl kinase, POH and limonene were tested for antileukemia activity. POH, but not limonene selectively induced G0/G1 arrest followed by apoptosis in Bcr/Abl-transformed, but not nontransformed FDC.P1 and 32D myeloid cell lines. In contrast to their greater sensitivity to POH, Bcr/Abl-transformed cells were more resistant than nontransformed cells to several chemotherapy agents and ionizing irradiation. Since in Bcr/Abl-transformed cells, POH induces apoptosis associated with G0/G1 arrest, POH must activate an apoptotic pathway that is not protected by the Bcr/Abl-induced G2/M delay. Monoterpenes may represent novel agents for treating Ph+ leukemias.
authors.affiliation: Department of Medicine, University of Wisconsin, Madison, WI 53792, USA.
authors.forename: M B
authors.initials: MB
authors.lastname: Sahin
authors.forename: S M
authors.initials: SM
authors.lastname: Perman
authors.forename: G
authors.initials: G
authors.lastname: Jenkins
authors.forename: S S
authors.initials: SS
authors.lastname: Clark
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D019556:COS Cells; D002461:Cell Line, Transformed; D019008:Drug Resistance, Neoplasm; D004354:Drug Screening Assays, Antitumor; D016044:Fusion Proteins, bcr-abl / Q000502:physiology*; D016193:G1 Phase / Q000187:drug effects*; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000473:pathology; D039821:Monoterpenes; D011836:Radiation Tolerance; D016192:Resting Phase, Cell Cycle / Q000187:drug effects*; D013329:Structure-Activity Relationship; D013729:Terpenes / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D039821:Monoterpenes; D013729:Terpenes; C032208:perillyl alcohol; D016044:Fusion Proteins, bcr-abl